Chief Medical Officer · Beta Bionics, Inc. · Common Stock
Side
SELL
Value
$30K
Shares
1,025
Price
$29.34
Executed
Dec 2, 2025
Disclosed
Mar 16, 2026
Disclosure timeline104 days from execution to publication · legal deadline 2 business days
Dec 2 executedMar 16, 2026 disclosed
BBNX · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 74 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering+15 / 15
6 other actors traded the same direction within 14 days
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Russell Steven Jon filed this Form 4 reporting a open-market sale of BBNX on Dec 2, 2025. It became public on Mar 16, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Chief Medical Officer
Russell Steven Joncik:0002051384
Issuer
Beta Bionics, Inc.cik:0001674632
Revision history · 0
No field has changed since this record was first ingested.
